Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Our findings suggest that hepatic dysregulation of Poldip2 may contribute to diabetic dyslipidemia and hyperglycemia. 31351995 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Inhibition of MAP-kinases demonstrated that, unlike Erk1/2, p38 MAPK is an upstream activator in a signaling cascade leading to increased arginase I in HG conditions. 31150695 2019
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Swiprosin-1 deficiency in early DN attenuated mitochondria-dependent podocyte apoptosis induced by hyperglycemia or HG via p38 MAPK signaling pathway. 29421811 2018
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE In the process of early DN, microinflammation and activation of p38 mitogen‑activated protein kinase (MAPK) and canonical nuclear factor (NF)-κB signaling pathways are the important mechanisms by which hyperglycemia contributes to glomerulosclerosis (GS). 28731135 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Dextrose-induced hyperglycaemia causes the impairment of endothelial cell proliferation and migration and inhibits the activation of ERK, p38 and Akt pathways. 28962618 2017
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Here we show that hyperglycemia increases the hydrogen peroxide (H2O2) concentration through up-regulation of manganese superoxide dismutase (SOD2) expression, which further activates the ERK and p38 MAPK pathways, as well as the transcription factors NF-κB and AP-1, in a time-dependent manner. 26439801 2015
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE Our results indicated the considerably aberrant MAPK signaling in both insulin-sensitive tissues of T2D rat, and that the p38 may play a role as a common "hub" in the gene module response to hyperglycaemia. 25758573 2014
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Taken together, these results indicate that hyperglycemia-induced TXNIP expression is involved in diabetes-mediated oxidative stress in pancreatic cancer via p38 MAPK and ERK pathways. 24720336 2014
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 AlteredExpression disease BEFREE Finally, significant activation of p38 MAPK was also observed in platelets from type 2 diabetic patients with mild hyperglycemia. 12957654 2003
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE The findings indicate that ang II and hyperglycaemia stimulate the TGF-beta 1 gene activation through the same PKC- and p38 MAPK-dependent pathways by the same regulatory elements of the TGF-beta 1 promoter. 12107734 2002
CUI: C0020456
Disease: Hyperglycemia
Hyperglycemia
0.100 Biomarker disease BEFREE We have characterized the effect of hyperglycemia on p38 mitogen-activated protein (p38) kinase activation, which can be induced by oxidants, hyperosmolarity, and proinflammatory cytokines, leading to apoptosis, cell growth, and gene regulation. 9916130 1999